- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Ikonisys SA: Suspension of Trading of Shares on Euronext Growth Paris Until the Publication of the 2024 Annual Report | 208 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| IKONISYS Aktie jetzt für 0€ handeln | |||||
| Di | XFRA 9W8: AUSSETZUNG/SUSPENSION | 201 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILIKONISYS EO 2 9W8... ► Artikel lesen | |
| 04.06. | ALIKO SCIENTIFIC (Ikonisys SA), Through Its Fully Owned Italian Subsidiary Hospitex International, Signs Exclusive Distribution Agreement for Italy with Menarini Diagnostics | 220 | Business Wire | Regulatory News:
ALIKO SCIENTIFIC (Ikonisys SA) Euronext Growth: ALIKO, through its fully owned Italian subsidiary Hospitex International is pleased to announce the signing of an exclusive distribution... ► Artikel lesen | |
| 30.05. | Ikonisys SA: Ikonisys Announces a Further Postponement of the Publication of Its 2024 Annual Financial Report | 271 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 02.05. | Ikonisys SA: Ikonisys Finalized a Capital Increase Through the Offsetting of Debt | 267 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 25.04. | Ikonisys Announces the Postponement of the Publication of Its 2024 Annual Financial Report | 246 | Business Wire | Regulatory News:
ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution... ► Artikel lesen | |
| 03.04. | Ikonisys SA: Hospitex International Launches Urine24, the First-Online Urinary Cytology Test Platform, Marking a Breakthrough in Early Bladder Cancer Diagnosis in Italy | 298 | Business Wire | Regulatory News:
ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), announces that its Italian subsidiary Hospitex International has launched Urine24.com, the first online-available... ► Artikel lesen | |
| 10.03. | Ikonisys SA Wins Public Tender with F. Miulli Regional General Hospital for Pathological Anatomy | 241 | Business Wire | Regulatory News:
Hospitex, the Italian leader in the production of Cytology medical devices and fully owned subsidiary of ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), a company... ► Artikel lesen | |
| 27.02. | Ikonisys SA: Ikonisys Finalized a Capital Increase Through a Private Placement | 454 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 05.02. | Ikonisys' Subsidiary Hospitex Secures a Major UN-Funded Contract for Hospital IT and Networking Systems in Ethiopia | 458 | Business Wire | Regulatory News:
ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), today announces that its subsidiary Hospitex, the Italian leader in the production of medical devices, has secured... ► Artikel lesen | |
| 27.01. | Ikonisys Secures U.S. Patent for "Automated Fluorescence Microscopy Method to Determine the Efficacy of Cancer and Hyperplasia Treatments" | 341 | Business Wire | Regulatory News:
Ikonisys Inc., a leader in advanced cell-based diagnostic solutions fully owned by ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), is proud to announce the grant... ► Artikel lesen | |
| 15.01. | Ikonisys: Hospitex Secures Major Public Tender for "Gaetano Martino" University Hospital in Messina | 261 | Business Wire | Regulatory News:
Hospitex, the Italian leader in the production of medical devices and a subsidiary of ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), today announces that it has... ► Artikel lesen | |
| 10.01. | Ikonisys SA: Ikonisys finalized a capital increase through the offsetting of debt | 328 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 31.12.24 | Ikonisys Finalized the Acquisition of Hospitex with the Issuance of 2M New Shares to ETH Scientific | 445 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 04.12.24 | The Ikonisys Group Unveils its New Vision and Strategy Under the Brand "ALIKO SCIENTIFIC" | 523 | Business Wire | Regulatory News:
ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique fully automated solution... ► Artikel lesen | |
| 25.11.24 | Ikonisys SA: Ikonisys Group Secures Major Public Contract for Ikoniscope20 Robotic Microscope in Italy | 132 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique fully automated solution for medical analysis... ► Artikel lesen | |
| 19.11.24 | Ikonisys SA: Ikonisys Completed a Capital Increase Through a Private Placement | 261 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 18.11.24 | Ikonisys SA: Ikonisys Group enters Central America Market through a Partnership and Distribution Agreement with Green Med Panama | 402 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique fully automated solution for medical analysis... ► Artikel lesen | |
| 12.11.24 | Ikonisys SA: Ikonisys Group Renews Agreement as European Authorized Representative and Importer for Novodiax's CE IVD-Certified Real-Time Immunohistochemistry Technology in Oncological Diagnostics and Organ Transplant Safety | 448 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique fully automated solution for medical analysis... ► Artikel lesen | |
| 04.11.24 | Ikonisys SA: Ikonisys to Start Collaboration with SYNLAB Italy to Introduce Ikoniscope in Pathology Laboratories | 583 | Business Wire | Regulatory News:
Ikonisys (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen |
1 2 Weiter >>
35 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 46,550 | -0,81 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS | 42,240 | -0,35 % | Aktie von Fresenius SE & Co. KGaA: Kurs heute nahezu konstant (42,73 €) | Die Wertschätzung für den Anteilsschein von Fresenius SE & Co. KGaA hat sich am Aktienmarkt heute kaum geändert. Das Wertpapier notiert zur Stunde bei 42,73 Euro. Kaum auffällig ist derzeit an der Börse... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 47,400 | -1,00 % | Aktien im Fokus: Stimmungsumschwung bei Nvidia, Analysten zurückhaltend bei FMC, De.mem erwartet Boom bei Wasseraufbereitung | ||
| CARL ZEISS MEDITEC | 53,30 | -1,02 % | ANALYSE-FLASH: UBS belässt Carl Zeiss Meditec auf 'Neutral' | ZÜRICH (dpa-AFX Broker) - Die Schweizer Großbank UBS hat Carl Zeiss Meditec auf "Neutral" belassen. In Gesprächen mit Investoren in Europa habe er ein gestiegenes Interesse an Medizintechnikunternehmen... ► Artikel lesen | |
| GERRESHEIMER | 48,900 | +0,12 % | Gerresheimer-Aktie verliert 3,41 Prozent (46,48 €) | Der Anteilsschein von Gerresheimer notiert heute etwas leichter. Die Aktie kostete zuletzt 46,48 Euro. Ein Abschlag von 3,41 Prozent steht gegenwärtig für der Anteilsschein von Gerresheimer zu Buche.... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 13,520 | -0,66 % | Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition | Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 membersExceeds high-end of Q1 guidance on membership... ► Artikel lesen | |
| NUTEX HEALTH | 116,79 | -4,50 % | Nutex Health, Inc.: Nutex Health Reports First Quarter 2025 Financial Results | TOTAL REVENUE OF $211.8 MILLION VERSUS $67.5 MILLION IN Q1 2024, AN INCREASE OF 213.8%
NET INCOME ATTRIBUTABLE TO NUTEX HEALTH INC. OF $14.6 MILLION VERSUS NET... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 22,040 | +0,18 % | BrightSpring Health Leads Companies In Line For Triple-Digit Profit Growth | ||
| GOODRX | 4,815 | -4,75 % | GoodRx (GDRX) Unveils Lifecycle to Enhance Engineering Methodologies | ||
| ECKERT & ZIEGLER | 66,40 | -0,60 % | Eckert&Ziegler mit BLITZMELDUNG: Eigener Vorstand kauft massiv Anteile - Das dürfen Sie auf keinen Fall verpassen! | ||
| UNITEDHEALTH | 262,25 | -0,23 % | Märkte am Morgen: Vonovia, Munich Re, Zalando, Nike, UnitedHealth, Boeing | Der DAX kommt in dieser Woche nicht in die Gänge. Gestern rutschte er nach ordentlichem Start ab und schloss deutlich im Minus. Damit hat er beide Tage in dieser mit Verlusten beendet. Heute gibt es... ► Artikel lesen | |
| HIMS & HERS HEALTH | 39,600 | -2,94 % | Dr. Dennis Riedl: Bitcoin, Hims & Hers und Paypal im Check | ||
| LIFEMD | 12,280 | -5,03 % | Hims & Hers vs. LifeMD: Which Telehealth Stock Has More Upside? | ||
| PHETON | 18,500 | +0,65 % | Pheton Holdings Ltd - S-8, Securities to be offered to employees in employee benefit plans | ||
| CONCENTRA GROUP | 20,605 | -0,17 % | Concentra Group Holdings Parent, Inc. Announces Closing of Pivot Onsite Innovations Acquisition | ADDISON, Texas--(BUSINESS WIRE)--Concentra Group Holdings Parent, Inc. ("Concentra," "the Company," "we," "us," or "our") (NYSE: CON), the nation's largest provider of occupational health services,... ► Artikel lesen |
IKONISYS gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 1,470 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu IKONISYS finden Sie auf Wallstreet Online.